Recombinant human collagen type iii and methods of making and using the same
By designing specific amino acid sequences and optimizing codon bias, recombinant human type III collagen was expressed in Pichia pastoris, which solved the problem of low activity of recombinant collagen and achieved efficient transdermal absorption and significant effects in promoting skin repair and moisturizing.
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- SHANGHAI YUSONG BIOTECHNOLOGY CO LTD
- Filing Date
- 2025-12-17
- Publication Date
- 2026-06-02
AI Technical Summary
In the existing technology, there are problems such as low activity of recombinant collagen during the preparation process and ineffective or inhibitory effect on the expression of some beneficial target proteins.
By designing recombinant human type III collagen with a specific amino acid sequence, expressing it in Pichia pastoris using genetic engineering technology, optimizing codon bias to improve expression efficiency, and performing appropriate chemical and fluorescent modifications, the product's high hydrophilicity and humanized characteristics are ensured.
It improved the transdermal absorption efficiency of recombinant human type III collagen, reduced the risk of allergic reactions, and significantly regulated gene expression in fibroblasts and keratinocytes, promoting cell proliferation and migration, and enhancing skin repair and moisturizing capabilities.
Smart Images

Figure CN121342961B_ABST